About their pathological roles, particularly in cancer diseases (Table 1), PARP6 contributes to the maintenance of centrosome integrity by MARylating the checkpoint kinase and promoting the breast cancer growth [78], while PARP15 is overexpressed in B-aggressive lymphoma [79] and acute myeloid leukemia [80]. Here, PARP6 is linked to breast cancer.